Breaking News Instant updates and real-time market news.

FB

Facebook

$150.42

6.21 (4.31%)

17:05
01/30/19
01/30
17:05
01/30/19
17:05

Facebook CEO says focused on making progress on social issues

Says believes it built "most advanced systems in the world" in many areas. Says will take "strong execution" through 2019 and beyond until has systems at necessary levels. Says focused on making progress on social issues, building new experiences to "meaningfully improve" lives, building business to support other businesses, and communicating more transparently about how Facebook's services exist in the world. Comments taken from Q4 earnings conference call.

  • 30

    Jan

  • 25

    Feb

  • 03

    Mar

FB Facebook
$150.42

6.21 (4.31%)

01/28/19
FBCO
01/28/19
NO CHANGE
Target $208
FBCO
Outperform
Facebook price target lowered to $208 at Credit Suisse ahead of quarterly result
Credit Suisse analyst Stephen Ju lowered his price target for Facebook to $208 from $210 ahead of quarterly results. The analyst notes that the stock thesis for Facebook shares at this point is similar to what he highlighted in 2017 heading into 2018, where the clearing data point for a more material recovery will likely be on the Q3 of 2019 results where the company will offer a CapEx outlook for 2020 to signal whether free cash flow will return to growth. Near-term and specific to Q4 of 2018 results, his advertiser checks continue to suggest modest deceleration for the Facebook app accompanied by ongoing budget share gains for Instagram. As for Stories, advertiser feedback for the core Facebook property, suggest adoption/experimentation will begin in earnest in Q1 of 2019, the analyst adds. Ju reiterates an Outperform rating on the shares.
01/28/19
WEDB
01/28/19
NO CHANGE
Target $220
WEDB
Outperform
Facebook to continue rapid growth overseas, says Wedbush
Wedbush analyst Michael Pachter expects Facebook to continue its rapid growth overseas and to increase monetization of under-penetrated Instagram, WhatsApp, and Messenger. The analyst anticipates Q4 results above consensus when Facebook reports earnings on Wednesday, January 30. Overall ad impressions growth should drive results this quarter, following double-digit year-over-year percent increases in each of the past two quarters, reflecting continued growth in Stories and video ads, Pachter contends. He reiterates an Outperform rating and $220 price target on the shares.
01/28/19
BMOC
01/28/19
NO CHANGE
Target $163
BMOC
Market Perform
Facebook price target lowered to $163 from $175 at BMO Capital
BMO Capital analyst Daniel Salmon lowered his price target on Facebook to $163, saying that while he expects higher revenues from Instagram and Stories ads, he also sees lower sales from the company's IG Feed and total advertising based on last week's AdExchanger industry conference. The analyst also keeps his Market Perform rating on Facebook, which he sees as reflective of his more cautious view on the company's margins. Salmon adds that visibility for Facebook remains low, and in order for the company to outperform, its Custom Audiences capabilities must not be hindered by regulation, and its agencies/brands must not be hurt by negative press.
01/25/19
JPMS
01/25/19
NO CHANGE
Target $195
JPMS
Overweight
JPMorgan remains positive on Facebook into Q4 results
JPMorgan analyst Doug Anmuth remains positive on Facebook into the company's Q4 results on January 30. The analyst views investor sentiment as mixed heading into the print. He expects to see "steady overall engagement" with Instagram strength and core Facebook facing an easier time spent comp from a year ago. Further, Anmuth believes expectations for 40%-50% operating expenditure growth in 2019 is well understood. He keeps an Overweight rating on the shares with a $195 price target.

TODAY'S FREE FLY STORIES

EXPGY

Experian

$0.00

(0.00%)

04:42
06/18/19
06/18
04:42
06/18/19
04:42
Downgrade
Experian rating change  »

Experian downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:00
06/18/19
06/18
04:00
06/18/19
04:00
General news
EGB yields decline with Treasury rates »

EGB yields decline with…

03:15
06/18/19
06/18
03:15
06/18/19
03:15
General news
FX Action: USD-CAD has settled near 1.3400 »

FX Action: USD-CAD has…

02:45
06/18/19
06/18
02:45
06/18/19
02:45
General news
FX Update: Sterling has hit fresh lows, and the yen has remained bid »

FX Update: Sterling has…

02:00
06/18/19
06/18
02:00
06/18/19
02:00
General news
Asian Market Wrap »

Asian Market Wrap:…

GE

General Electric

$10.04

-0.2 (-1.95%)

21:05
06/17/19
06/17
21:05
06/17/19
21:05
Periodicals
General Electric to cut another 450 jobs in Switzerland, Reuters says »

General Electric will lay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJG

Arthur J. Gallagher

$86.25

-1.52 (-1.73%)

20:00
06/17/19
06/17
20:00
06/17/19
20:00
Hot Stocks
Arthur J. Gallagher acquires P2 Group, terms not stated »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

AGLNF

AGL Energy

$0.00

(0.00%)

19:28
06/17/19
06/17
19:28
06/17/19
19:28
Upgrade
AGL Energy rating change at Macquarie »

AGL Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWR

SunPower

$8.27

0.03 (0.36%)

, RUN

Sunrun

$17.09

0.64 (3.89%)

19:02
06/17/19
06/17
19:02
06/17/19
19:02
Upgrade
SunPower, Sunrun, SolarEdge rating change at Goldman Sachs »

SunPower, Sunrun upgraded…

SPWR

SunPower

$8.27

0.03 (0.36%)

RUN

Sunrun

$17.09

0.64 (3.89%)

SEDG

SolarEdge

$56.58

0.09 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGI

MoneyGram

$1.44

-0.06 (-4.00%)

, PHAS

PhaseBio

$12.25

0.74 (6.43%)

18:48
06/17/19
06/17
18:48
06/17/19
18:48
Hot Stocks
Fly Intel: After Hours Movers »

HIGHER: MoneyGram (MGI)…

MGI

MoneyGram

$1.44

-0.06 (-4.00%)

PHAS

PhaseBio

$12.25

0.74 (6.43%)

SPWR

SunPower

$8.27

0.03 (0.36%)

RUN

Sunrun

$17.09

0.64 (3.89%)

STLD

Steel Dynamics

$26.23

-0.19 (-0.72%)

BHVN

Biohaven Pharmaceutical

$57.33

-5.63 (-8.94%)

RMTI

Rockwell Medical

$4.39

0.2 (4.77%)

CALA

Calithera Biosciences

$5.87

0.64 (12.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 18

    Jun

  • 19

    Jun

AAPL

Apple

$193.90

1.06 (0.55%)

18:44
06/17/19
06/17
18:44
06/17/19
18:44
Periodicals
Apple's tvOS 13 beta 2 includes Picture-in-Picture support, 9to5Mac reports »

Apple's tvOS 13 beta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEDG

SolarEdge

$56.58

0.09 (0.16%)

18:33
06/17/19
06/17
18:33
06/17/19
18:33
Upgrade
SolarEdge rating change at Goldman Sachs »

SolarEdge upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RUN

Sunrun

$17.09

0.64 (3.89%)

18:33
06/17/19
06/17
18:33
06/17/19
18:33
Upgrade
Sunrun rating change at Goldman Sachs »

Sunrun upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWR

SunPower

$8.27

0.03 (0.36%)

18:33
06/17/19
06/17
18:33
06/17/19
18:33
Upgrade
SunPower rating change at Goldman Sachs »

SunPower upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLSFY

Bluescope Steel

$0.00

(0.00%)

18:32
06/17/19
06/17
18:32
06/17/19
18:32
Hot Stocks
Bluescope Steel cuts FY19 EBIT growth view to up 6% from up 10% »

BlueScope announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

International Flavors

$147.54

-1.25 (-0.84%)

18:24
06/17/19
06/17
18:24
06/17/19
18:24
Hot Stocks
International Flavors CEO: We have planned for Brexit and China is benign for us »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$57.63

-0.65 (-1.12%)

18:24
06/17/19
06/17
18:24
06/17/19
18:24
Periodicals
Senator aims to bar Huawei from seeking damages in patent courts, Reuters says »

U.S. Senator Marco Rubio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 20

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

  • 01

    Aug

BHVN

Biohaven Pharmaceutical

$57.33

-5.63 (-8.94%)

18:12
06/17/19
06/17
18:12
06/17/19
18:12
Hot Stocks
Breaking Hot Stocks news story on Biohaven Pharmaceutical »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISH

Dish

$39.00

1.46 (3.89%)

18:04
06/17/19
06/17
18:04
06/17/19
18:04
Hot Stocks
Dish launches OnTech Smart Services »

Dish announced the launch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$32.30

-0.06 (-0.19%)

18:03
06/17/19
06/17
18:03
06/17/19
18:03
Hot Stocks
AT&T wins 24 GHz spectrum following FCC Auction 102 »

AT&T is the winning…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

BHVN

Biohaven Pharmaceutical

$57.33

-5.63 (-8.94%)

18:02
06/17/19
06/17
18:02
06/17/19
18:02
Syndicate
Biohaven Pharmaceutical offers to sell $300M in common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSM

Versum Materials

$51.42

0.01 (0.02%)

, MKGAY

Merck KGaA

$0.00

(0.00%)

18:01
06/17/19
06/17
18:01
06/17/19
18:01
Hot Stocks
Versum Materials shareholders approve merger with Merck KGaA »

Versum Materials (VSM)…

VSM

Versum Materials

$51.42

0.01 (0.02%)

MKGAY

Merck KGaA

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

VLO

Valero

$76.93

0.19 (0.25%)

18:00
06/17/19
06/17
18:00
06/17/19
18:00
Periodicals
Valero restarting Port Arthur, Texas refinery hydrocracker, Reuters says »

Valero is restarting the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

VLO

Valero

$76.93

0.19 (0.25%)

17:59
06/17/19
06/17
17:59
06/17/19
17:59
Periodicals
Valero restarting Meraux, Louisiana refinery hydrocracker, Reuters says »

Valero is restarting the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

MGI

MoneyGram

$1.44

-0.06 (-4.00%)

17:44
06/17/19
06/17
17:44
06/17/19
17:44
Hot Stocks
MoneyGram spikes almost 140% after blockchain company Ripple investment »

Money transfer company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.